Raymond James Financial Issues Pessimistic Forecast for Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price target reduced by Raymond James Financial from $52.00 to $50.00 in a research note released on...
Romios Gold Resources (CVE:RG) Trading Up 25% – Here’s What Happened
Romios Gold Resources Inc. (CVE:RG – Get Free Report) shot up 25% on Saturday . The stock traded as high as C$0.03 and last traded...
Romios Gold Resources (CVE:RG) Trading 25% Higher – Here’s What Happened
Shares of Romios Gold Resources Inc. (CVE:RG – Get Free Report) traded up 25% during mid-day trading on Saturday . The company traded as high...
Romios Gold Resources (CVE:RG) Shares Up 25% – Time to Buy?
Romios Gold Resources Inc. (CVE:RG – Get Free Report)’s share price traded up 25% on Saturday . The company traded as high as C$0.03 and...
Hemostemix (CVE:HEM) Stock Price Down 16.7% – Time to Sell?
Shares of Hemostemix Inc. (CVE:HEM – Get Free Report) traded down 16.7% on Saturday . The stock traded as low as C$0.10 and last traded...
Hemostemix (CVE:HEM) Stock Price Down 16.7% – Should You Sell?
Shares of Hemostemix Inc. (CVE:HEM – Get Free Report) fell 16.7% during mid-day trading on Saturday . The company traded as low as C$0.10 and...